Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 NOK | -1.46% | -7.73% | -22.52% |
Mar. 14 | Hofseth BioCare ASA Announces Board Changes | CI |
Feb. 09 | Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2022 | 120M 10.93M | Sales 2023 | 219M 19.82M | Capitalization | 1.04B 93.89M |
---|---|---|---|---|---|
Net income 2022 | -137M -12.43M | Net income 2023 | -107M -9.71M | EV / Sales 2022 | 11.4 x |
Net Debt 2022 | 71.74M 6.51M | Net Debt 2023 | 257M 23.3M | EV / Sales 2023 | 5.91 x |
P/E ratio 2022 |
-8.89
x | P/E ratio 2023 |
-9.7
x | Employees | 70 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.78% |
1 day | -1.46% | ||
1 week | -7.73% | ||
Current month | -2.40% | ||
1 month | -2.40% | ||
3 months | -21.32% | ||
6 months | -27.50% | ||
Current year | -22.52% |
Managers | Title | Age | Since |
---|---|---|---|
Jon Olav Ødegård
CEO | Chief Executive Officer | 51 | 13-02-28 |
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
Director/Board Member | 53 | 15-04-30 | |
Director/Board Member | 49 | 15-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 2.03 | -1.46% | 70,767 |
24-04-29 | 2.06 | -1.44% | 34,575 |
24-04-26 | 2.09 | -0.48% | 43,478 |
24-04-25 | 2.1 | -4.55% | 101,046 |
24-04-24 | 2.2 | +0.46% | 4,265 |
Real-time Oslo Bors, April 30, 2024 at 10:45 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-22.52% | 72.44M | |
-5.45% | 264B | |
-2.41% | 96.77B | |
-1.89% | 46.94B | |
-0.03% | 40.26B | |
+7.45% | 39.78B | |
+3.89% | 39.6B | |
-19.18% | 29.43B | |
-5.77% | 28.95B | |
+11.36% | 24.86B |
- Stock Market
- Equities
- HBC Stock